NCI Takes Site-Wide License to Partek Genomic Suite | GenomeWeb
NEW YORK (GenomeWeb News) - The National Cancer Institute has purchased site-wide licenses to Partek’s Genomic Suite, the company announced today.
 
The suite is a statistical and visual data analysis software package that can handle thousands of samples and millions of variables in a genomics experiment, according to Partek.
 
Financial terms of the deal were not released.
 
Every researcher at NCI will have access to the suite as a result of the transaction, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.